Biotechnology Assets Balance Sheet Health
Financial Health criteria checks 3/6
Biotechnology Assets has a total shareholder equity of €6.5M and total debt of €4.1M, which brings its debt-to-equity ratio to 62.7%. Its total assets and total liabilities are €16.6M and €10.1M respectively. Biotechnology Assets's EBIT is €2.7M making its interest coverage ratio 8.8. It has cash and short-term investments of €416.9K.
Key information
62.7%
Debt to equity ratio
€4.09m
Debt
Interest coverage ratio | 8.8x |
Cash | €416.87k |
Equity | €6.53m |
Total liabilities | €10.08m |
Total assets | €16.61m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 041's short term assets (€3.8M) exceed its short term liabilities (€3.6M).
Long Term Liabilities: 041's short term assets (€3.8M) do not cover its long term liabilities (€6.5M).
Debt to Equity History and Analysis
Debt Level: 041's net debt to equity ratio (56.3%) is considered high.
Reducing Debt: 041's debt to equity ratio has reduced from 224% to 62.7% over the past 5 years.
Debt Coverage: 041's debt is not well covered by operating cash flow (1.2%).
Interest Coverage: 041's interest payments on its debt are well covered by EBIT (8.8x coverage).